Research location
Haag in Oberbayern
Germany
Advertisement
Research activity in Haag in Oberbayern
GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 10 trials and 10 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Haag in Oberbayern
10 linked trials · page 1 of 1A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's DiseaseNCT05642442 · 2022-12-01 · 1 site observation
COMPLETED
An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's DiseaseNCT05543252 · 2022-08-29 · 1 site observation
TERMINATED
Open-label Trial in Parkinson's Disease (PD)NCT04760769 · 2021-02-24 · 1 site observation
COMPLETED
A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's DiseaseNCT04658186 · 2020-12-30 · 1 site observation
COMPLETED
Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)NCT04542499 · 2020-09-23 · 1 site observation
COMPLETED
Fixed-Dose Trial in Early Parkinson's Disease (PD)NCT04201093 · 2019-12-13 · 1 site observation
COMPLETED
Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor FluctuationsNCT03877510 · 2019-04-03 · 1 site observation
COMPLETED
A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)NCT03391882 · 2018-12-19 · 1 site observation
COMPLETED
A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's DiseaseNCT02726386 · 2016-05-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's PatientsNCT02453386 · 2015-07-01 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.